Tardigrade proteins lead to human health breakthrough.
Originally Published 2 years ago — by Phys.org
Researchers at the University of Wyoming have discovered that proteins from tardigrades can be used to stabilize an important pharmaceutical used to treat people with hemophilia and other conditions without the need for refrigeration. The pharmaceutical, known as human blood clotting Factor VIII, is critical in treating patients with genetic disease and instances of extreme bleeding, but is inherently unstable. The researchers believe the same thing can be done with other biologics, such as vaccines, antibodies, stem cells, blood and blood products, and that this will be beneficial for global health initiatives in remote or developing parts of the world.